Iopamiro

Iopamidol, the active ingredient in Iopamiro, is a non‑ionic iodinated contrast agent presented as a sterile solution for injection for intraarterial and intravenous use. It enhances radiographic visualization of vascular and tissue structures during diagnostic imaging procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iopamiro (iopamidol) is used as an iodinated contrast medium in radiographic procedures to improve image quality.

Contrast‑enhanced CT of head, chest, abdomen and pelvis: provides high‑contrast images for accurate diagnosis. Angiography (arterial and venous): enhances visualization of blood vessels during catheter‑based studies. Myelography and urography: improves delineation of cerebrospinal fluid spaces and urinary tract structures.

Adverse reactions to Iopamiro may vary from mild to severe and are reported in clinical practice.

Common Side Effects: - Warm sensation or flushing at injection site - Metallic taste in the mouth - Mild nausea or vomiting - Headache - Transient injection site pain

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury or contrast‑induced nephropathy - Severe hypotension or cardiovascular collapse - Seizures - Pulmonary edema - Cardiac arrhythmias

Prior to administering Iopamiro, clinicians should observe several precautionary measures to minimize risk.

Renal function assessment: evaluate baseline kidney function and consider hydration status. Allergy history: verify no prior adverse reactions to iodine‑based contrast agents. Hydration: ensure adequate patient hydration before and after the procedure. Concurrent nephrotoxic drugs: avoid or closely monitor use of NSAIDs, aminoglycosides, or other renal‑impairing agents. Pregnancy and lactation: use only if clearly necessary after risk‑benefit assessment. Store at ambient temperature: keep in original container, protect from light and moisture.

Iopamiro may interact with certain medications, affecting safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis; discontinue before contrast administration. - Iodinated thyroid medications: may precipitate thyroid dysfunction. - High‑dose steroids: increase risk of contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and blood pressure. - Diuretics: adjust fluid balance to prevent dehydration. - NSAIDs: may potentiate renal adverse effects; use with caution.